Top News
-
An unpredictable environment: navigating triggers in atopic dermatitis (Galderma Group AG)
Public Technologies 2026-10-09, 10:01) Why does the world around us impact atopic dermatitis? For people living with atopic dermatitis, choosing...
-
Fall Clinical 2026: Galderma Presents New Three-Year Nemluvio® Data Showing Deep and Lasting Skin Lesion ...
Killeen Daily Herald 2026-10-08, 11:01New Nemluvio® (nemolizumab) post-hoc data from the ARCADIA long-term extension (LTE) study showed the majority...
-
Fall Clinical 2026: Galderma Presents New Three-Year Nemluvio� Data Showing Deep and Lasting Skin Lesion ...
Business Wire 2026-10-08, 08:40New Nemluvio® (nemolizumab) post-hoc data from the ARCADIA long-term extension (LTE) study showed the...
-
For menopause-related skin changes, aesthetic treatments are gaining ground (Galderma Group AG)
Public Technologies 2026-10-07, 10:55) Most women are not aware of the effects menopause can have on their skin health and appearance More than 30%...
-
EADV 2026: Galderma's New Data Show Sustained Improvements with Nemluvio� (nemolizumab) for up to Three ...
Business Wire 2026-09-30, 12:00New three-year ARCADIA long-term extension data demonstrate that Nemluvio is well-tolerated and associated...
-
EADV 2026: Galderma’s new data show sustained improvements with Nemluvio® (nemolizumab) for up to three years in patients with moderate-to-severe atopic dermatitis (Galderma Group AG)
Public Technologies 2026-09-30, 07:00) New three-year ARCADIA long-term extension data demonstrate that Nemluvio is well-tolerated and associated...
-
Galderma and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully complete negotiations for NEMLUVIO® (nemolizumab), for moderate-to-severe ...
Canada Newswire 2026-09-28, 15:21This is another key milestone in offering patients with atopic dermatitis (AD) and prurigo nodularis (PN)...
-
EADV 2026: Galderma’s scientific presentations and activities (Galderma Group AG)
Public Technologies 2026-09-23, 05:56) Galderma will present 19 abstracts advancing understanding of skin diseases, skin longevity, and real-world...
-
Galderma Begins Trading in the Swiss Market Index, Joining Switzerland's Leading Blue Chip Companies
Business Wire 2026-09-22, 12:33ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play...
-
Galderma begins trading in the Swiss Market Index, joining Switzerland's leading blue chip companies (Galderma Group AG)
Public Technologies 2026-09-21, 07:02) Zug, Switzerland, September 21, 2026 - Galderma (SIX: GALD), the pure-play dermatology category leader,...
-
Landmark Global Galderma Survey Shows 9 out of 10 People Are Affected by Skin Quality Concerns
Business Wire 2026-07-07, 16:49ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SWX:GALD) has unveiled results...